Did you know?
While lung transplantation was initially used as a treatment for pulmonary fibrosis and pulmonary hypertension, the indications have evolved such that emphysema is the most common diagnosis leading to transplantation, accounting for 39% of transplants worldwide. Approximately 50% of lung transplant recipients are older than 50 years, which is the age group characteristic of COPD and interstitial pulmonary fibrosis.
Read the Full Article: http://www.medscape.com/viewarticle/502203_6
Photo by Matt Hall on the Rubicon Trail